Quest Diagnostics (DGX) reported Q1 adjusted earnings Tuesday of $2.21 per diluted share, up from $2.04 a year earlier.
Analysts polled by FactSet expected $2.15.
Revenue for the quarter ended March 31 was $2.65 billion, up from $2.37 billion a year earlier.
Analysts surveyed by FactSet expected $2.63 billion.
For 2025, the medical diagnostics company reaffirmed its adjusted diluted EPS expectation of $9.55 to $9.80.
Analysts polled by FactSet expect $9.68.
Shares of the company were down more than 3.5% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。